Health-care Disruptors: New Models Changing the Landscape

Details
Watch Next

Details

Traditional models of medical product research and development and health-care delivery are being disrupted, as incentives for research and care shift and technology opens up new opportunities. Hospitals and universities are shaking up conventional approaches to their roles. New investment models are emerging for financing early-stage R&D all the way to product approval and access. What is behind these transformations, and what will the health-care and research landscape look like for patients and investors over the next few years?

Custom Author Text

Moderator

Casey Ross National Technology Correspondent, STAT

Speakers

Ray Dorsey David M. Levy Professor of Neurology, University of Rochester

Joel Dudley Associate Professor of Genetics and Genomic Sciences and Founding Director of the Institute for Next Generation Healthcare, Icahn School of Medicine, Mount Sinai

Andrea Feinberg Chief Health Officer, Geisinger Innovation

Dan Liljenquist Senior Vice President and Chief Strategy Officer, Intermountain Healthcare

Opioid Addiction: A Crisis Fueled by Stigma

125 views

Opening Plenary | Part 1: A Conversation with Maxine Waters, United States Representative, California | Part 2: The Future of Brain Health

105 views

The Business Case for Addressing Social Determinants of Health

93 views

Lunch Program | Part 1: A Conversation with Alex Azar, Secretary, US Department of Health and Human Services | Part 2: Optimizing Health Through Food

116 views

Health-care Disruptors: New Models Changing the Landscape

Watch Next

21st Century Medicine: Are We There Yet?

A Conversation with Elizabeth Blackburn

A Conversation with FDA Commissioner Scott Gottlieb

A Conversation with Francis Collins, Director, National Institutes of Health